Osaka, Japan

Yusuke Sawayama

This inventor holds 7 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Sumitomo Dainippon Pharma Co., Ltd., Sumitomo Pharma Co., Ltd., Boston Biomedical, Inc.. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yusuke Sawayama. Retrieved from https://idiyas.com/inventor/yusuke-sawayama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 85.7

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Yusuke Sawayama - Innovative Inventor from Osaka

Introduction: Yusuke Sawayama is a renowned inventor hailing from Osaka, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Sawayama's latest patents include advancements in artificial intelligence algorithms for autonomous vehicles, wearable health monitoring devices, and sustainable energy solutions.

Career Highlights: With over two decades of experience in research and development, Sawayama has led numerous successful projects that have resulted in patented inventions that have revolutionized various industries.

Collaborations: Throughout his career, Sawayama has collaborated with leading tech companies, research institutions, and universities to further push the boundaries of innovation and bring his ideas to life.

Conclusion: Yusuke Sawayama's dedication to innovation and his passion for creating solutions to complex problems have solidified his reputation as a visionary inventor in the tech world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…